$PGR

Griffith Susan Patricia sold $8.2M of PGR

Griffith Susan Patricia (President and CEO) sold 37,338 shares of PROGRESSIVE CORP/OH/ (PGR) at $219.50 ($8.20M total) on 2026-09-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Griffith Susan Patricia
Published Sep 2, 2026, 6:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 2, 2026, 7:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PGR
Bearish
high confidence
Mentioned
$PGR
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PGRBearishMed
01

Why it matters

The disclosed sale reduces insider ownership, which may be interpreted as a lack of confidence, potentially prompting short‑term selling pressure.

02

Market read

Insider sell of $8.2M by the CEO is a material event for traders monitoring PGR, offering a possible short‑term trade idea.

03

What to watch

Potential tax planning or diversification motives behind the 10b5-1 sale are not disclosed.

Relevance 5/10Novelty 6/10Timing: filing date 2026-09-02, immediate market impact possible

Background

Form 4 filings disclose insider transactions; a sale by the CEO is closely watched by market participants.

Company-level read

Ticker impact

$PGRBearishHigh confidence
Context

CEO Susan Patricia Griffith sold 37,338 shares for $8.2M via a 10b5-1 plan, reducing her stake to 485,438 shares.

Expected impact

Potential modest downside pressure over the next few trading sessions.

Evidence & confidence

The sale amount is sizable for an insider and was executed through a pre‑arranged plan, indicating a deliberate reduction of exposure.

Market effects

Minimal; the transaction is specific to Progressive Corp and does not affect the broader insurance sector.

U.S. market only; no regional ripple effects expected.

Low; limited to investors tracking insider activity.

Counterpoint

The sale could be routine portfolio rebalancing; the stock may remain stable if fundamentals stay strong.

Key entities

  • Progressive Corp.

    U.S. insurance provider (ticker PGR).

  • Susan Patricia Griffith

    President, CEO, and Director of Progressive Corp.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PGRHighAI 8/10

Progressive (PGR) Reports Q3 Earnings Beat, Revenue Misses Expectations

Progressive (PGR) reported Q3 earnings of $4.6 per share, beating estimates by 3.14%, but revenue of $23.36 billion missed expectations by 0.22%. The company has exceeded EPS estimates for four consecutive quarters. Shares are down 2.1% YTD. The next quarter's EPS estimate is $4.02 with revenue expected at $23.15 billion. The insurance sector is currently in the top 26% of Zacks industries. United Fire Group (UFCS) is expected to report a 20.7% YOY earnings decline.

$PGRHigh

Wells Fargo cuts Progressive stock price target on growth concerns

Wells Fargo reduced its price target on Progressive Corp. (PGR) to $196 from $201, citing policy losses and higher accident year loss ratios. The firm lowered its 2027 earnings estimate by 2.4%, remaining 13.1% below consensus. Progressive trades at a P/E ratio of 10.69 and is set to report earnings on October 14. Other analysts have mixed ratings and price targets, with some expecting outperformance.

$PGRMedAI 8/10

Progressive earnings analysis: questions answered and next catalysts

Progressive Corp (PGR) reported Q3 FY2026 earnings with EPS of $4.37, missing estimates by 1.13%, and revenue of $22.30B, missing expectations by $200M. The stock fell 6.35%. Growth slowed, but underwriting remains strong. Analysts expect EPS to peak in FY2026 and decline thereafter, with revenue still forecast to rise. Key catalysts include Q4 results, monthly performance, catastrophe losses, and estimate revisions.